Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
23232 | 353 | 27.7 | 61% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
143 | 3 | EPILEPSY//EPILEPSIA//EPILEPSY & BEHAVIOR | 64226 |
230 | 2 | ANTIEPILEPTIC DRUGS//LEVETIRACETAM//EPILEPSY | 20331 |
23232 | 1 | RUFINAMIDE//CLOBAZAM//LENNOX GASTAUT SYNDROME | 353 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | RUFINAMIDE | authKW | 4072509 | 18% | 74% | 64 |
2 | CLOBAZAM | authKW | 2661373 | 18% | 49% | 63 |
3 | LENNOX GASTAUT SYNDROME | authKW | 2068309 | 22% | 30% | 79 |
4 | DROP SEIZURES | authKW | 617864 | 3% | 71% | 10 |
5 | N DESMETHYLCLOBAZAM | authKW | 615122 | 2% | 89% | 8 |
6 | TOTAL SEIZURES | authKW | 259505 | 1% | 100% | 3 |
7 | IHARAS GENETICALLY EPILEPTIC RAT IGER | authKW | 173004 | 1% | 100% | 2 |
8 | PERSONALITY DISORDERS DRUG THERAPY | authKW | 173004 | 1% | 100% | 2 |
9 | CHILD FAMILIY HLTH SERV | address | 115334 | 1% | 67% | 2 |
10 | IHARA EPILEPTIC RAT | authKW | 115334 | 1% | 67% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Clinical Neurology | 6858 | 60% | 0% | 212 |
2 | Pharmacology & Pharmacy | 704 | 27% | 0% | 97 |
3 | Pediatrics | 328 | 11% | 0% | 40 |
4 | Psychiatry | 190 | 9% | 0% | 33 |
5 | Neurosciences | 83 | 11% | 0% | 40 |
6 | Medical Laboratory Technology | 52 | 2% | 0% | 8 |
7 | Behavioral Sciences | 49 | 3% | 0% | 11 |
8 | Toxicology | 33 | 4% | 0% | 13 |
9 | Medicine, General & Internal | 15 | 5% | 0% | 17 |
10 | Crystallography | 12 | 2% | 0% | 8 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CHILD FAMILIY HLTH SERV | 115334 | 1% | 67% | 2 |
2 | KLIN NEUROPADIATRIE NEUROL REHABIL | 111213 | 1% | 43% | 3 |
3 | ASSOCIATE SCIENTIST | 86502 | 0% | 100% | 1 |
4 | BIOL MOL PL MED | 86502 | 0% | 100% | 1 |
5 | CEAINSERM U1129NEUROPEDIAT | 86502 | 0% | 100% | 1 |
6 | CEAINSERM U1129NEUROPEDIAT REFERENCE | 86502 | 0% | 100% | 1 |
7 | CHILD ADOLESCENT NEUROPSYCHIAT MED | 86502 | 0% | 100% | 1 |
8 | CHILDRENS HOSPASAN MED PEDIAT NEUROL | 86502 | 0% | 100% | 1 |
9 | CLIN NEUROPAEDIAT NEUROREHABILITAT | 86502 | 0% | 100% | 1 |
10 | CLIN NEUROPEDIATR NEUROL REHABIL | 86502 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EPILEPSIA | 22399 | 14% | 1% | 48 |
2 | SEIZURE-EUROPEAN JOURNAL OF EPILEPSY | 6969 | 4% | 1% | 14 |
3 | EPILEPSY RESEARCH | 6443 | 5% | 0% | 17 |
4 | CLINICAL ELECTROENCEPHALOGRAPHY | 5585 | 2% | 1% | 7 |
5 | EPILEPTIC DISORDERS | 4195 | 2% | 1% | 7 |
6 | EPILEPSY CURRENTS | 2832 | 1% | 2% | 2 |
7 | EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY | 2814 | 2% | 1% | 6 |
8 | EPILEPSY & BEHAVIOR | 2553 | 3% | 0% | 11 |
9 | THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS | 2258 | 1% | 1% | 2 |
10 | THERAPEUTIC DRUG MONITORING | 1470 | 2% | 0% | 8 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | RUFINAMIDE | 4072509 | 18% | 74% | 64 | Search RUFINAMIDE | Search RUFINAMIDE |
2 | CLOBAZAM | 2661373 | 18% | 49% | 63 | Search CLOBAZAM | Search CLOBAZAM |
3 | LENNOX GASTAUT SYNDROME | 2068309 | 22% | 30% | 79 | Search LENNOX+GASTAUT+SYNDROME | Search LENNOX+GASTAUT+SYNDROME |
4 | DROP SEIZURES | 617864 | 3% | 71% | 10 | Search DROP+SEIZURES | Search DROP+SEIZURES |
5 | N DESMETHYLCLOBAZAM | 615122 | 2% | 89% | 8 | Search N+DESMETHYLCLOBAZAM | Search N+DESMETHYLCLOBAZAM |
6 | TOTAL SEIZURES | 259505 | 1% | 100% | 3 | Search TOTAL+SEIZURES | Search TOTAL+SEIZURES |
7 | IHARAS GENETICALLY EPILEPTIC RAT IGER | 173004 | 1% | 100% | 2 | Search IHARAS+GENETICALLY+EPILEPTIC+RAT+IGER | Search IHARAS+GENETICALLY+EPILEPTIC+RAT+IGER |
8 | PERSONALITY DISORDERS DRUG THERAPY | 173004 | 1% | 100% | 2 | Search PERSONALITY+DISORDERS+DRUG+THERAPY | Search PERSONALITY+DISORDERS+DRUG+THERAPY |
9 | IHARA EPILEPTIC RAT | 115334 | 1% | 67% | 2 | Search IHARA+EPILEPTIC+RAT | Search IHARA+EPILEPTIC+RAT |
10 | PAROXYSMAL FAST ACTIVITY | 115334 | 1% | 67% | 2 | Search PAROXYSMAL+FAST+ACTIVITY | Search PAROXYSMAL+FAST+ACTIVITY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SEIF-EDDEINE, H , NG, YT , (2012) CLOBAZAM FOR PATIENTS WITH LENNOX-GASTAUT SYNDROME AND EPILEPSY.EXPERT REVIEW OF NEUROTHERAPEUTICS. VOL. 12. ISSUE 4. P. 385-393 | 47 | 66% | 5 |
2 | NG, YT , COLLINS, SD , (2007) CLOBAZAM.NEUROTHERAPEUTICS. VOL. 4. ISSUE 1. P. 138-144 | 37 | 86% | 41 |
3 | GAUTHIER, AC , MATTSON, RH , (2015) CLOBAZAM: A SAFE, EFFICACIOUS, AND NEWLY REDISCOVERED THERAPEUTIC FOR EPILEPSY.CNS NEUROSCIENCE & THERAPEUTICS. VOL. 21. ISSUE 7. P. 543 -548 | 34 | 74% | 4 |
4 | WHELESS, JW , PHELPS, SJ , (2013) CLOBAZAM: A NEWLY APPROVED BUT WELL-ESTABLISHED DRUG FOR THE TREATMENT OF INTRACTABLE EPILEPSY SYNDROMES.JOURNAL OF CHILD NEUROLOGY. VOL. 28. ISSUE 2. P. 219-229 | 33 | 79% | 8 |
5 | KLEHM, J , THOME-SOUZA, S , FERNANDEZ, IS , BERGIN, AM , BOLTON, J , HARINI, C , KADISH, NE , LIBENSON, M , PETERS, J , PODURI, A , ET AL (2014) CLOBAZAM: EFFECT ON FREQUENCY OF SEIZURES AND SAFETY PROFILE IN DIFFERENT SUBGROUPS OF CHILDREN WITH EPILEPSY.PEDIATRIC NEUROLOGY. VOL. 51. ISSUE 1. P. 60 -66 | 29 | 83% | 3 |
6 | COPPOLA, G , BESAG, F , CUSMAI, R , DULAC, O , KLUGER, G , MOAVERO, R , NABBOUT, R , NIKANOROVA, M , PISANI, F , VERROTTI, A , ET AL (2014) CURRENT ROLE OF RUFINAMIDE IN THE TREATMENT OF CHILDHOOD EPILEPSY: LITERATURE REVIEW AND TREATMENT GUIDELINES.EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY. VOL. 18. ISSUE 6. P. 685 -690 | 25 | 93% | 4 |
7 | HSIEH, DT , THIELE, EA , (2013) EFFICACY AND SAFETY OF RUFINAMIDE IN PEDIATRIC EPILEPSY.THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. VOL. 6. ISSUE 3. P. 189-198 | 29 | 81% | 6 |
8 | GROSSO, S , COPPOLA, G , DONTIN, SD , GOBBI, G , PRUNA, D , ACCORSI, EP , VERROTTI, A , PARISI, P , BALESTRI, P , (2014) EFFICACY AND SAFETY OF RUFINAMIDE IN CHILDREN UNDER FOUR YEARS OF AGE WITH DRUG-RESISTANT EPILEPSIES.EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY. VOL. 18. ISSUE 5. P. 641 -645 | 25 | 89% | 2 |
9 | DE LEON, J , SPINA, E , DIAZ, FJ , (2013) CLOBAZAM THERAPEUTIC DRUG MONITORING: A COMPREHENSIVE REVIEW OF THE LITERATURE WITH PROPOSALS TO IMPROVE FUTURE STUDIES.THERAPEUTIC DRUG MONITORING. VOL. 35. ISSUE 1. P. 30-47 | 41 | 53% | 10 |
10 | FAULKNER, MA , (2015) COMPREHENSIVE OVERVIEW: EFFICACY, TOLERABILITY, AND COST-EFFECTIVENESS OF CLOBAZAM IN LENNOX-GASTAUT SYNDROME.THERAPEUTICS AND CLINICAL RISK MANAGEMENT. VOL. 11. ISSUE . P. - | 27 | 73% | 1 |
Classes with closest relation at Level 1 |